TrialSpark

Formation Bio

New York, United States · Founded 2016 · $598.0M raised

Headquarters
New York, New York
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$598.0M
Last Round
$156.0M Series CJan 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

TrialSpark was a New York City-based clinical trial technology company founded in 2016 by Benjamine Liu, Linhao Zhang, and Kit Dobyns with the goal of building a technology-driven pharma company differentiated by radically more efficient drug development. The company built proprietary technology platforms and processes to optimize critical aspects of clinical drug development including site operations, patient recruitment, data management, and regulatory workflows. TrialSpark operated a network of clinical trial sites and developed software infrastructure to modernize trial execution. The company raised approximately $226 million in venture funding from investors including GV and a16z. In December 2023, TrialSpark rebranded as Formation Bio, reflecting its evolved strategy of partnering with, acquiring, or in-licensing late-stage drug assets from pharma companies to develop them using its AI-powered platform.

Summary

TrialSpark is a Biotech company based in New York, United States, founded in 2016. It has raised $598.0M in total across 4 rounds, most recently a $156.0M Series C round in Jan 2024. Investors include Sequoia Capital, Thrive Capital and Sam Altman.

Tech & App Stack

9 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries C2024 (est.)
$156.0M

Sign up to see all 4 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TrialSpark on Indexed.vc
<a href="https://indexed.vc/companies/trialspark"><img src="https://indexed.vc/api/badge/company/trialspark" alt="TrialSpark on Indexed.vc" width="260" height="76" /></a>